Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula empírica (notación de Hill):
C38H80NBr
Número CAS:
Peso molecular:
630.95
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleassay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 g (890810P-1g), pkg of 1 × 200 mg (890810P-200mg), pkg of 1 × 25 mg (890810P-25mg), pkg of 1 × 500 mg (890810P-500mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
application(s)
vaccine development
lipid type
cationic lipids
transfection
shipped in
dry ice
storage temp.
−20°C
SMILES string
CCCCCCCCCCCCCCCCCC[N+](CCCCCCCCCCCCCCCCCC)(C)C.[Br-]
InChI
1S/C38H80N.BrH/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39(3,4)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2;/h5-38H2,1-4H3;1H/q+1;/p-1
InChI key
PSLWZOIUBRXAQW-UHFFFAOYSA-M
General description
18:0 DDAB is cationic lipid and a quaternary ammonium salt. The hydrocarbon tails are saturated unlike the ionizable lipids.
Application
18:0 DDAB is suitable for the preparation of lipid-nanoparticles. It has also been used as an adjuvant and combined with monophosphoryl lipid A (MPL) for immunizing mice.
Biochem/physiol Actions
18:0 DDAB is a surface-active molecule, used as an adjuvant to induce systemic immune response. It is non-toxic.
Packaging
5 mL Amber Glass Screw Cap Vial (890810P-200mg)
20 mL Clear Glass Screw Cap Vial (890810P-1g)
5 mL Amber Glass Screw Cap Vial (890810P-25mg)
20 mL Clear Glass Screw Cap Vial (890810P-500mg)
Other Notes
For R&D use only. Not for drug, household, or other uses.
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigens
Klinguer C, et al.
Vaccine, 19(30), 4236-4244 (2001)
Ana Cristina Norberto Oliveira et al.
ACS applied materials & interfaces, 6(9), 6977-6989 (2014-04-10)
This study describes a novel liposomal formulation for siRNA delivery, based on the mixture of the neutral lipid monoolein (MO) and cationic lipids of the dioctadecyldimethylammonium (DODA) family. The cationic lipids dioctadecyldimethylammonium bromide (DODAB) and chloride (DODAC) were compared in
Hong Yu et al.
Infection and immunity, 80(4), 1510-1518 (2012-02-01)
Major impediments to a Chlamydia vaccine lie in discovering T cell antigens and polarizing adjuvants that stimulate protective immunity. We previously reported the discovery of three T cell antigens (PmpG, PmpF, and RplF) via immunoproteomics that elicited protective immunity in